Trademark: 86983758
Word
ONCOTRIALS
Status
Registered
Status Code
702
Status Date
Saturday, January 6, 2024
Serial Number
86983758
Registration Number
5459576
Registration Date
Tuesday, May 1, 2018
Mark Type
4000
Filing Date
Monday, January 4, 2016
Published for Opposition
Tuesday, January 10, 2017

Trademark Owner History
Flatiron Health, Inc. - Original Registrant

Classifications
35 Management and compilation of computerized databases; Electronic data collection and data submission services for business purposes in the fields of oncology, medicine, life science and healthcare; Collection and compilation of information into computer databases in the fields of oncology, medicine, life science and healthcare; Business consulting and management in the field of patient data, namely, management and compilation of computerized databases in the field of oncology patient data for business purposes; Providing an on-line database providing business intelligence in the fields of oncology, medicine, life science and healthcare; Managing databases for the design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; Managing databases for data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and regarding clinical trials for pharmaceuticals, medical devices and medical procedures
42 Data mining; Providing temporary use of on-line non-downloadable cloud computing software for in aggregating, integrating, analyzing, standardizing, managing and reporting of data in clinical trials, clinical data, financial data, electronic medical records data, medical practice management data and billing data in real time from heterogeneous data sources, and for database management in the fields of oncology, medicine, life science and healthcare; Providing temporary use of on-line non-downloadable cloud computing software for use in data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and regarding clinical trials for pharmaceuticals, medical devices and medical procedures; Providing temporary use of on-line non-downloadable cloud computing software for use in analyzing business and clinical intelligence data in the fields of fields of oncology, medicine, life science and healthcare; Providing temporary use of on-line non-downloadable cloud computing software for data compilation for research purposes in the fields of oncology, medicine, life science and healthcare; Development, updating and maintenance of software and databases in the fields of oncology, medicine, life science and healthcare; Providing temporary use of on-line non-downloadable cloud computing software for use in design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; Providing temporary use of on-line non-downloadable cloud computing software for the tracking and management of patients, schedules, and performance milestones and metrics involved in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures; Application service provider, namely, hosting, managing, developing, and maintaining web sites, software, applications, and databases for data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and regarding clinical trials for pharmaceuticals, medical devices and medical procedures; Application service provider, namely, hosting, managing, developing, and maintaining web sites, software, and applications for the design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; Application service provider, namely, hosting, managing, developing, and maintaining web sites, software, and applications for the tracking and management of patients, schedules, and performance milestones and metrics involved in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures
ONCO TRIALS

Trademark Events
Jan 6, 2024
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Jan 6, 2024
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jan 6, 2024
Case Assigned To Post Registration Paralegal
Jul 12, 2023
Teas Section 8 & 15 Received
May 1, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Mar 1, 2022
Teas Change Of Correspondence Received
Mar 1, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 1, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 9, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 9, 2020
Teas Change Of Correspondence Received
Sep 9, 2020
Teas Withdrawal Of Attorney Received-Firm Retains
Sep 9, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 9, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 9, 2020
Teas Change Of Owner Address Received
May 1, 2018
Registered-Principal Register
Mar 28, 2018
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 27, 2018
Allowed Principal Register - Sou Accepted
Mar 16, 2018
Statement Of Use Processing Complete
Mar 12, 2018
Use Amendment Filed
Mar 16, 2018
Divisional Processing Complete
Mar 12, 2018
Divisional Request Received
Mar 12, 2018
Teas Request To Divide Received
Mar 12, 2018
Teas Statement Of Use Received
Mar 6, 2018
Notice Of Approval Of Extension Request E-Mailed
Mar 2, 2018
Sou Extension 2 Granted
Mar 2, 2018
Sou Extension 2 Filed
Mar 2, 2018
Sou Teas Extension Received
Sep 2, 2017
Notice Of Approval Of Extension Request E-Mailed
Sep 1, 2017
Sou Extension 1 Granted
Aug 25, 2017
Sou Extension 1 Filed
Sep 1, 2017
Case Assigned To Intent To Use Paralegal
Aug 25, 2017
Sou Teas Extension Received
May 3, 2017
Teas Change Of Correspondence Received
Mar 7, 2017
Noa E-Mailed - Sou Required From Applicant
Jan 10, 2017
Official Gazette Publication Confirmation E-Mailed
Jan 10, 2017
Published For Opposition
Dec 21, 2016
Notification Of Notice Of Publication E-Mailed
Dec 3, 2016
Law Office Publication Review Completed
Nov 23, 2016
Approved For Pub - Principal Register
Nov 22, 2016
Teas/Email Correspondence Entered
Nov 22, 2016
Correspondence Received In Law Office
Nov 22, 2016
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 7, 2016
Assigned To Lie
Oct 26, 2016
Teas Response To Office Action Received
Oct 14, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 14, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 26, 2016
Notification Of Non-Final Action E-Mailed
Apr 26, 2016
Non-Final Action E-Mailed
Apr 26, 2016
Non-Final Action Written
Apr 20, 2016
Assigned To Examiner
Jan 13, 2016
Notice Of Pseudo Mark E-Mailed
Jan 12, 2016
New Application Office Supplied Data Entered
Jan 7, 2016
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24